• Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
  • JAK2 Gene Mutation (V617F) Analysis
  • Thyroxine, Free (FT4)
  • Heroin, Urine
  • Cytomegalovirus (CMV) Antibody, IgG
  • Toxoplasma IgG and IgM
  • PM-1 (PM-Scl) Antibody
  • Oxycodone and Metabolites, Confirmation, Urine
  • Tumor Suppressor Gene P53 (TP53) Gene Mutation Analysis, Li-Fraumeni Syndrome
  • Heavy Metals Screen, Random, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Complement Component CH50
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Complement Component CH50
Medical Test

Methodology
Access to Complement Component CH50 is restricted.